This event has ended. Visit the official site or create your own event on Sched.
View analytic
Monday, September 18 • 2:45pm - 4:00pm
The NYU Psilocybin Cancer Project

Sign up or log in to save this to your schedule and see who's attending!

Psychedelic-assisted psychotherapy is a new area of clinical research unknown to most clinicians. This session will report on the history of psychedelic-assisted psychotherapy for cancer-related psychological and existential distress. Dr. Ross will discuss findings of a recently published randomized controlled trial of psilocybin-assisted psychotherapy for cancer-related psychological and existential distress. 

avatar for Stephen Ross, MD

Stephen Ross, MD

Associate Professor, Department of Psychiatry, New York University of Medicine; Senior Director, Division of Alcoholism and Drug Abuse, Department of Psychiatry, Bellevue Hospital | | Stephen Ross, M.D. is Associate Professor of Psychiatry and Child & Adolescent Psychiatry at the New York University (NYU) School of Medicine and Associate Professor of Oral and Maxillofacial Pathology, Radiology and Medicine at the NYU College of Dentistry. Dr. Ross is the Director of the Division of Alcoholism and Drug Abuse in the Psychiatry Department at Bellevue Hospital Center, Director of Addiction Psychiatry at NYU Langone Medical Center/Tisch Hospital, and the Director of the NYU Addiction Fellowship. | | Dr. Ross directs a National Institute of Health funded Addictive Disorders Laboratory at Bellevue Hospital Center and is the Director of the NYU Psychedelic Research Group. Dr. Ross researches the therapeutic application of hallucinogen treatment models to treat psychiatric and addictive disorders. He is an expert in psycho-oncology and is studying novel pharmacologic-psychosocial approaches to treating psychological distress associated with advanced or terminal cancer. Dr. Ross is the Principal Investigator (PI) of the NYU Psilocybin Cancer Project (a recently completed FDA phase II RCT studying the efficacy of psilocybin-assisted psychotherapy in patients with life-threatening cancer and psychological/existential distress), PI of a controlled trial administering psilocybin to religious professionals, and co-PI of a controlled trial assessing psilocybin-assisted psychotherapy in patients with alcoholism. Dr. Ross receives his research funding from the National Institute on Drug Abuse, the NYU School of Medicine and the Heffter Research Institute... Read More →

Monday September 18, 2017 2:45pm - 4:00pm
Hall E-2 The New Orleans Ernest N. Morial Convention Center 900 Convention Center Boulevard New Orleans, LA 70130